ArrowMark Colorado Holdings’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-714,807
Closed -$2.41M 319
2023
Q3
$2.41M Sell
714,807
-527,672
-42% -$3.47M 0.03% 228
2023
Q2
$10.3M Buy
1,242,479
+76,002
+7% +$684K 0.11% 144
2023
Q1
$10.2M Sell
1,166,477
-308,660
-21% -$3.43M 0.12% 138
2022
Q4
$18M Sell
1,475,137
-99,089
-6% -$942K 0.22% 95
2022
Q3
$10M Sell
1,574,226
-13,079
-0.8% -$111K 0.12% 150
2022
Q2
$14.3M Buy
1,587,305
+818,318
+106% +$7.2M 0.16% 127
2022
Q1
$8.89M Buy
768,987
+208,193
+37% +$3.2M 0.08% 202
2021
Q4
$9.85M Buy
560,794
+459,364
+453% +$10.1M 0.08% 194
2021
Q3
$2.3M Buy
+101,430
New +$3.33M 0.02% 280

Other funds holding SGHT

ArrowMark Colorado Holdings's SGHT Position: Q4 2023 in Review

ArrowMark Colorado Holdings sold out of Sight Sciences (SGHT) in Q4 2023, closing a stake of 714,807 shares — an estimated $2.41M sold.

ArrowMark Colorado Holdings first reported a position in SGHT in Q3 2021 and held it in 9 quarters. The position peaked at $18M in Q4 2022. 65 funds tracked by Wall St. Rank hold SGHT as of Q4 2023.

  • ArrowMark Colorado Holdings reported no remaining Sight Sciences position as of Q4 2023 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 714,807 Sight Sciences shares in Q4 2023, an estimated $2.41M.
  • ArrowMark Colorado Holdings first reported a position in Sight Sciences in Q3 2021 and held it in 9 quarters.
  • ArrowMark Colorado Holdings's Sight Sciences position peaked at $18M in Q4 2022.
  • 65 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.